Tucaliv 150mg Tablet (Tucatinib)

Tucatinib 150mg Tablet is primarily used for:

• HER2-positive metastatic breast cancer
• Advanced HER2-positive breast cancer
• Breast cancer with brain metastases
• Combination targeted therapy in oncology

It is usually administered as part of combination treatment plans for better therapeutic effectiveness.

The medicine is especially beneficial for patients who have previously received anti-HER2 therapies.

Tucatinib works by selectively inhibiting HER2 tyrosine kinase receptors present on cancer cells.

• Blocks HER2 signaling pathways
• Prevents cancer cell growth and division
• Reduces tumor progression
• Helps destroy HER2-positive cancer cells

This targeted mechanism reduces damage to healthy cells while effectively controlling cancer growth.

Tucatinib is highly selective for HER2 receptors, which helps minimize certain side effects associated with less selective therapies.

Take Tucatinib 150mg Tablet exactly as prescribed by your oncologist.

• Usually taken twice daily
• Can be taken with or without food
• Swallow whole with water
• Do not crush or chew the tablet

Treatment duration and dosage depend on individual patient response and combination therapy protocols.

Never stop or change the dose without medical supervision.

• Targeted HER2-positive cancer treatment
• Improves progression-free survival
• Effective against brain metastases
• Helps slow tumor growth
• Convenient oral administration
• Supports long-term cancer management

Tucatinib offers a modern precision-oncology approach and has significantly improved treatment outcomes for HER2-positive cancer patients.

Common side effects may include:

• Diarrhea
• Nausea and vomiting
• Fatigue
• Loss of appetite
• Abdominal pain
• Hand-foot syndrome

Serious side effects may include:

• Liver toxicity
• Severe diarrhea
• Dehydration

Regular medical monitoring is important during treatment.

• Use only under oncologist supervision
• Avoid during pregnancy
• Use effective contraception
• Monitor liver function regularly
• Maintain hydration during treatment
• Inform doctor about existing health conditions

Seek immediate medical help if severe diarrhea, jaundice, or breathing difficulties occur.

Tucatinib 150mg Tablet may interact with:

• CYP2C8 inhibitors or inducers
• Other anticancer medicines
• Liver-affecting drugs
• Herbal supplements

Always provide your doctor with a complete list of medicines and supplements.

• Store below 25°C
• Protect from moisture and sunlight
• Keep out of reach of children
• Store in original packaging

• 100% Genuine Oncology Medicines
• Affordable International Pricing
• Secure Packaging & Delivery
• Fast Worldwide Shipping
• Trusted Online Pharmacy
• Dedicated Customer Support

We ensure authentic oncology products with professional service and reliable delivery support.

Q1: What is Tucatinib 150mg Tablet used for?
It is used for HER2-positive metastatic breast cancer.

Q2: Is Tucatinib chemotherapy?
No, it is a targeted HER2 inhibitor.

Q3: Can it treat brain metastases?
Yes, it is effective in HER2-positive cancers with brain metastases.

Q4: How should I take Tucatinib?
Usually twice daily as directed by your oncologist.

Q5: Is long-term treatment possible?
Yes, under continuous medical supervision.